1. Jagsonpal Pharmaceuticals
stock logo

Jagsonpal Pharmaceuticals Share Price

JAGSNPHARM

₹343.00+₹10.85 (3.27%) TodayLast updated on 24 May, 2024 | 03:29 PM IST
₹333.40₹350.00
L
Show Current Price
H
  • Company overview

  • Fundamentals

  • Events

  • More

Company overview

Financial performance

arrow

Market cap

Market Cap Switch₹905 Crs

Open

₹333.40

Close

₹332.15

Circuit range

₹398.55 - ₹265.75

Day range

₹333.40 - ₹350.00

Year range

₹273.60 - ₹514.85

Volume

44,799

Avg. traded

₹344.25

Revenue (12m)

₹209 Crs

Jagsonpal PharmaceuticalsJagsonpal Pharmaceuticals Limited is an India-based pharmaceutical company. The Company is primarily engaged in the manufacturing and trading of pharmaceutical products and active pharmaceutical ingredients (APIs). Its formulation products include Divatrone, Maintane 500 injection, Maintane 250 injection, Maintane Tablet, Indocap capsules, Metadec 50 injection, Metadec 25 injection, EndoReg Tablet, LycoRed softgels, LycoRed syrup, Doxypal DR-L Capsule, Yuliprist Tablet, COLLA-2 Tablet, Cystelia M, and DeeReg Tablet, among others. Its OTC products include Ringcuter Cream, Skin Lumia Soap-Antibacterial, and Skin Lumia Soap-Neem Tulsi. Its Naari products include Endoreg, Yuliprist, Verena, Kyrah, Krampoff, Endonorm EV2, Divagest SR 300, Divagest SR 200, Cystelia 35, Fibristone 25, and Cystelia-M. Its other products include Lycored Softgels, Lycored Syrup, JP Tone Syrup, and Doxypal DR-L. The Company’s therapy areas include gynecology, orthopedics, and others.

Jagsonpal Pharmaceuticals Key indicators

arrow

52 week high

₹514.85

52 week low

₹273.60

P/E ratio

40.4

P/B ratio

4.8

ROE

18.89%

ROCE

24.15%

Dividend yield

1.54%

Debt/Equity ratio

EPS

10.2

Learn more

Investment checklist: (2/6)

arrow
check status

Equity returns

check status

Dividend returns

check status

Safety factor

check status

Growth factor

check status

Debt vs Equity

check status

Profit factor

The investment checklist helps you understand a company's financial health at a glance and identify quality investment opportunities easily

Fundamentals

Financial ratios

arrow
  • Profitability

  • Operational

  • Valuation

Operating profit margin

15.51%

Net profit margin

10.39%

ROE

18.89%

ROA

14.29%

ROCE

24.15%

Learn more

Jagsonpal Pharmaceuticals Shareholder returns

arrow

1 day

-3.39%

1 week

-2.02%

1 month

+2.01%

3 months

+8.10%

1 year

-5.88%

3 years

+238.24%

5 years

+1255.71%

Revenue statement

All values are in ₹ Crores (Cr)
arrow

Cash flow

All values are in ₹ Crores (Cr)
arrow

Balance sheet

All values are in ₹ Crores (Cr)
arrow

Jagsonpal Pharmaceuticals Share Price history

arrow
DayOpenCloseDay’s change
Fri, May 24 2024
₹333.40
₹342.15
+3.01%
Thu, May 23 2024
₹344.65
₹332.15
-3.39%
Wed, May 22 2024
₹351.65
₹343.80
-2.09%
Tue, May 21 2024
₹354.80
₹351.15
-2.74%
Sat, May 18 2024
₹361.00
₹361.05
+0.94%
Fri, May 17 2024
₹345.65
₹357.70
+5.52%
Thu, May 16 2024
₹329.80
₹339.00
+3.88%
Wed, May 15 2024
₹329.10
₹326.35
+0.65%

Shareholding info

arrow

Promoters (68.09%)

Mutual Funds (0%)

Retail and other (30.33%)

Foreign institutions-FII (0.73%)

Other domestic institutions (0.85%)

Promoters

Learn more

Events

Corporate actions

arrow
  • Dividend • ₹5/share

    Ex date 21 Aug 2023

    expand tab
  • Dividend • ₹4/share

    Ex date 29 Oct 2021

    expand tab

Learn more

Frequently asked questions